Literature DB >> 17048194

Cholesterol-lowering effect of concentrated pomegranate juice consumption in type II diabetic patients with hyperlipidemia.

Ahmad Esmaillzadeh1, Farideh Tahbaz, Iraj Gaieni, Hamid Alavi-Majd, Leila Azadbakht.   

Abstract

This study was undertaken to assess the effect of concentrated pomegranate juice consumption on lipid profiles of type II diabetic patients with hyperlipidemia (total cholesterol or triglycerides > or = 200 mg/dL). In this pilot study 22 diabetic patients were recruited from the Iranian Diabetes Society. They were free of any other chronic diseases. The patients were followed for eight weeks to obtain more detailed data about their diet before concentrated pomegranate juice (CPJ) consumption period began. In this pre-study period a 24-hour food recall and a food record (containing flavonoid-rich foodstuffs) were completed every ten days. At the end of the eighth week, anthropometric and biochemical assessments were done. Thereafter the patients consumed 40 g CPJ for eight weeks. During this period, dietary assessment was continued. After completion of the study anthropometric and blood indices were evaluated again. The Wilcoxon signed-rank test was used for statistical analysis. P-value was considered significant at p < 0.05. There were 14 women (63.6%) and 8 men (36.4%) in this survey. Mean (+/- SD) of age, weight, and duration of diabetes were 52.5 (+/- 5.2) years, 71.5 (+/- 10.3) kg, and 7.9 (+/- 6.6) years, respectively. After consumption of concentrated pomegranate juice significant reductions were seen in total cholesterol (p < 0.006), low-density lipoprotein-cholesterol (LDL-c) (p < 0.006), LDL-c/high-density lipoprotein-cholesterol (HDL-c) (p < 0.001), and total cholesterol/HDL-c (p < 0.001). However there were no significant changes in serum triacylglycerol and HDL-c concentrations. Anthropometric indices, physical activity level, types and doses of oral hypoglycemic agents, and the intake of nutrients and flavonoid-rich foodstuffs did not change during the CPJ consumption period. It is concluded that CPJ consumption could modify heart disease risk factors in these hyperlipidemic patients. Therefore, its inclusion in their diets may be beneficial.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17048194     DOI: 10.1024/0300-9831.76.3.147

Source DB:  PubMed          Journal:  Int J Vitam Nutr Res        ISSN: 0300-9831            Impact factor:   1.784


  27 in total

1.  Reduction of cisplatin ototoxicity in rats by oral administration of pomegranate extract.

Authors:  Zahide Mine Yazici; Aysenur Meric; Ahmet Midi; Yasar Volkan Arınc; Volkan Kahya; Gunter Hafız
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-03-27       Impact factor: 2.503

Review 2.  Role of Melt Curve Analysis in Interpretation of Nutrigenomics' MicroRNA Expression Data.

Authors:  Farid E Ahmed; Mostafa M Gouda; Laila A Hussein; Nancy C Ahmed; Paul W Vos; Mahmoud A Mohammad
Journal:  Cancer Genomics Proteomics       Date:  2017 Nov-Dec       Impact factor: 4.069

3.  Effect of pomegranate juice consumption on biochemical parameters and complete blood count.

Authors:  Eirini Manthou; Kalliopi Georgakouli; Chariklia K Deli; Aggelos Sotiropoulos; Ioannis G Fatouros; Dimitrios Kouretas; Serko Haroutounian; Chrysoula Matthaiou; Yiannis Koutedakis; Athanasios Z Jamurtas
Journal:  Exp Ther Med       Date:  2017-06-27       Impact factor: 2.447

4.  Pomegranate peel anthocyanins prevent diet-induced obesity and insulin resistance in association with modulation of the gut microbiota in mice.

Authors:  Haizhao Song; Xinchun Shen; Rou Deng; Qiang Chu; Xiaodong Zheng
Journal:  Eur J Nutr       Date:  2022-01-18       Impact factor: 5.614

5.  Consumption of hydrolyzable tannins-rich pomegranate extract suppresses inflammation and joint damage in rheumatoid arthritis.

Authors:  Meenakshi Shukla; Kalpana Gupta; Zafar Rasheed; Khursheed A Khan; Tariq M Haqqi
Journal:  Nutrition       Date:  2008-05-19       Impact factor: 4.008

6.  Ellagic Acid Suppresses ApoB Secretion and Enhances ApoA-1 Secretion from Human Hepatoma Cells, HepG2.

Authors:  Ayana Ieda; Maki Wada; Yuuki Moriyasu; Yuuko Okuno; Nobuhiro Zaima; Tatsuya Moriyama
Journal:  Molecules       Date:  2021-06-25       Impact factor: 4.411

7.  Chronic administration of a combination of six herbs inhibits the progression of hyperglycemia and decreases serum lipids and aspartate amino transferase activity in diabetic rats.

Authors:  Reza Shafiee-Nick; Ahmad Ghorbani; Farzaneh Vafaee Bagheri; Hassan Rakhshandeh
Journal:  Adv Pharmacol Sci       Date:  2012-12-09

8.  Preventive and prophylactic mechanisms of action of pomegranate bioactive constituents.

Authors:  Monica Viladomiu; Raquel Hontecillas; Pinyi Lu; Josep Bassaganya-Riera
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-30       Impact factor: 2.629

9.  Bioavailable constituents/metabolites of pomegranate (Punica granatum L) preferentially inhibit COX2 activity ex vivo and IL-1beta-induced PGE2 production in human chondrocytes in vitro.

Authors:  Meenakshi Shukla; Kalpana Gupta; Zafar Rasheed; Khursheed A Khan; Tariq M Haqqi
Journal:  J Inflamm (Lond)       Date:  2008-06-13       Impact factor: 4.981

10.  Pomegranate polyphenols lower lipid peroxidation in adults with type 2 diabetes but have no effects in healthy volunteers: a pilot study.

Authors:  Arpita Basu; Emily D Newman; Alecia L Bryant; Timothy J Lyons; Nancy M Betts
Journal:  J Nutr Metab       Date:  2013-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.